The European Food and Safety Authority (EFSA) has rejected claims a peptide blend included in infant formula could reduce the risk of developing atopic dermatitis.
The International Scientific Association for Probiotics and Prebiotics (ISAPP) has clarified the term ‘postbiotics’ in a statement that responds to the scientific groundswell and growing number of postbiotic applications.